Studies have simulated four relatively rare chromosomal rearrangements with unknown oncogenic potential in human brain glioma and have found that one of the chromosomal deletions results in fusion between BCAN and NTRK1, which promotes the formation of highly invasive glioma [21]. The gene discussed is BCAN; the disease is glioma.